Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elisabeth B. Stougaard"'
Autor:
Ninna H. Tougaard, Marie Frimodt-Møller, Hanne Salmenkari, Elisabeth B. Stougaard, Andressa D. Zawadzki, Ismo M. Mattila, Tine W. Hansen, Cristina Legido-Quigley, Sohvi Hörkkö, Carol Forsblom, Per-Henrik Groop, Markku Lehto, Peter Rossing
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 13, p 3573 (2022)
Type 1 diabetes is associated with increased intestinal inflammation and decreased abundance of butyrate-producing bacteria. We investigated the effect of butyrate on inflammation, kidney parameters, HbA1c, serum metabolites and gastrointestinal symp
Externí odkaz:
https://doaj.org/article/1e80e94e64314a26a3aa7989523fdc56
Autor:
Elisabeth B. Stougaard, Peter Rossing, Dorte Vistisen, Phillip Banks, Manon Girard, Michael J. Davies, Frederik Persson
Publikováno v:
Diabetes, Obesity and Metabolism.
Autor:
null Elisabeth B Stougaard, null Peter Rossing, null Dorte Vistisen, null Phillip Banks, null Manon Girard, null Michael J Davies, null Frederik Persson
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ee3c2bfc329665917fbe9ba77264faf
https://doi.org/10.1111/dom.15047/v2/response1
https://doi.org/10.1111/dom.15047/v2/response1
Autor:
Elisabeth B Stougaard, Peter L Kristensen, Urd Kielgast, Henrik U Andersen, Yasmin Hamid, Peter H Gæde, Esben Søndergaard, Gry H Dørflinger, Karen K Fjeldborg, Klavs W Hansen, Henrik H Thomsen, Thuraya M.J. Al-Imar, Michael Røder, Vikas S Sridhar, David Cherney, Peter Rossing, Frederik Persson
Publikováno v:
Stougaard, E B, Kristensen, P L, Kielgast, U, Andersen, H U, Hamid, Y, Gæde, P H, Søndergaard, E, Dørflinger, G H, Fjeldborg, K K, Hansen, K W, Thomsen, H H, Al-Imar, T M J, Røder, M, Sridhar, V S, Cherney, D, Rossing, P & Persson, F 2022, ' Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis ', Diabetes & vascular disease research, vol. 19, no. 5, pp. 14791641221130043 . https://doi.org/10.1177/14791641221130043
Stougaard, E B, Kristensen, P L, Kielgast, U, Andersen, H U, Hamid, Y, Gæde, P H, Søndergaard, E, Dørflinger, G H, Fjeldborg, K K, Hansen, K W, Thomsen, H H, Al-Imar, T M J, Røder, M, Sridhar, V S, Cherney, D, Rossing, P & Persson, F 2022, ' Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis ', Diabetes & vascular disease research, vol. 19, no. 5 . https://doi.org/10.1177/14791641221130043
Stougaard, E B, Kristensen, P L, Kielgast, U, Andersen, H U, Hamid, Y, Gæde, P H, Søndergaard, E, Dørflinger, G H, Fjeldborg, K K, Hansen, K W, Thomsen, H H, Al-Imar, T M J, Røder, M, Sridhar, V S, Cherney, D, Rossing, P & Persson, F 2022, ' Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis ', Diabetes & vascular disease research, vol. 19, no. 5 . https://doi.org/10.1177/14791641221130043
Background The indication for treatment of type 1 diabetes(T1D) with the sodium–glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin has been withdrawn in Europe likely because of concern for diabetic ketoacidosis (DKA). We calculated the incid
Autor:
Ninna H. Tougaard, Marie Frimodt-Møller, Hanne Salmenkari, Elisabeth B. Stougaard, Andressa D. Zawadzki, Ismo M. Mattila, Tine W. Hansen, Cristina Legido-Quigley, Sohvi Hörkkö, Carol Forsblom, Per-Henrik Groop, Markku Lehto, Peter Rossing
Publikováno v:
Tougaard, N H, Frimodt-Møller, M, Salmenkari, H, Stougaard, E B, Zawadzki, A D, Mattila, I M, Hansen, T W, Legido-Quigley, C, Hörkkö, S, Forsblom, C, Groop, P H, Lehto, M & Rossing, P 2022, ' Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes : A Randomized, Double-Blind, Placebo-Controlled Trial ', Journal of Clinical Medicine, vol. 11, no. 13, 3573 . https://doi.org/10.3390/jcm11133573
Journal of Clinical Medicine; Volume 11; Issue 13; Pages: 3573
Journal of Clinical Medicine; Volume 11; Issue 13; Pages: 3573
Type 1 diabetes is associated with increased intestinal inflammation and decreased abundance of butyrate-producing bacteria. We investigated the effect of butyrate on inflammation, kidney parameters, HbA1c, serum metabolites and gastrointestinal symp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::863ca9a63a6fec20851cb6a9b442685f
https://curis.ku.dk/ws/files/313502489/jcm_11_03573_v2.pdf
https://curis.ku.dk/ws/files/313502489/jcm_11_03573_v2.pdf
Publikováno v:
Journal of Diabetes and its Complications. 36:108257
Sodium-glucose cotransporter inhibitors (SGLTi) have beneficial cardiovascular and renal effects in persons with type 2 diabetes. No studies have shown whether this can be demonstrated in type 1 diabetes (T1D). We aimed to estimate the risk of cardio